Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooks Jackson

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2006
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and DTamara S Flys, Shu Chen, Dana C Jones, et al.
Journal of Virology|May 18, 2007
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populationsWei Huang, Susan H Eshleman, Jonathan Toma, et al.
Academic Pathology|July 7, 2018
The Evolution of Earned, Transparent, and Quantifiable Faculty Salary Compensation: The Johns Hopkins Pathology ExperienceKathleen H Burns, Michael J Borowitz, Karen C Carroll, et al.
AIDS Research and Human Retroviruses|June 26, 2009
In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapineJessica D Church, Anthony Mwatha, Danstan Bagenda, et al.
Current HIV Research|November 16, 2010
Analysis of HIV tropism in Ugandan infantsJessica D Church, Wei Huang, Anthony Mwatha, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionCraig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Diagnostic utility of telomere length testing in a hospital-based settingJonathan K Alder, Vidya Sagar Hanumanthu, Margaret A Strong, et al.
The Journal of Infectious Diseases|December 16, 2003
Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infectionJeffrey M Jacobson, Michael M Lederman, John Spritzler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2012
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmissionMichael G Hudgens, Taha E Taha, Saad B Omer, et al.
Lancet (London, England)|September 19, 2003
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialJ Brooks Jackson, Philippa Musoke, Thomas Fleming, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2006
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and DTamara S Flys, Shu Chen, Dana C Jones, et al.
Journal of Virology|May 18, 2007
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populationsWei Huang, Susan H Eshleman, Jonathan Toma, et al.
Academic Pathology|July 7, 2018
The Evolution of Earned, Transparent, and Quantifiable Faculty Salary Compensation: The Johns Hopkins Pathology ExperienceKathleen H Burns, Michael J Borowitz, Karen C Carroll, et al.
AIDS Research and Human Retroviruses|June 26, 2009
In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapineJessica D Church, Anthony Mwatha, Danstan Bagenda, et al.
Current HIV Research|November 16, 2010
Analysis of HIV tropism in Ugandan infantsJessica D Church, Wei Huang, Anthony Mwatha, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionCraig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Diagnostic utility of telomere length testing in a hospital-based settingJonathan K Alder, Vidya Sagar Hanumanthu, Margaret A Strong, et al.
The Journal of Infectious Diseases|December 16, 2003
Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infectionJeffrey M Jacobson, Michael M Lederman, John Spritzler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2012
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmissionMichael G Hudgens, Taha E Taha, Saad B Omer, et al.
Lancet (London, England)|September 19, 2003
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialJ Brooks Jackson, Philippa Musoke, Thomas Fleming, et al.
Pageof 14